Sträter R - Search Results

1

The factor V G1691A mutation is a risk for porencephaly: A case-control study.

Debus OM, Kosch A, Sträter R, Rossi R, Nowak-Göttl U. Debus OM, et al. Among authors: strater r. Ann Neurol. 2004 Aug;56(2):287-90. doi: 10.1002/ana.20184. Ann Neurol. 2004. PMID: 15293282

2

Ischaemic stroke in infancy and childhood: role of the Arg506 to Gln mutation in the factor V gene.

Nowak-Göttl U, Sträter R, Dübbers A, Oleszuk-Raschke K, Vielhaber H. Nowak-Göttl U, et al. Among authors: strater r. Blood Coagul Fibrinolysis. 1996 Oct;7(7):684-8. Blood Coagul Fibrinolysis. 1996. PMID: 8958390

3

Factor V Leiden and genetic defects of thrombophilia in childhood porencephaly.

Debus O, Koch HG, Kurlemann G, Sträter R, Vielhaber H, Weber P, Nowak-Göttl U. Debus O, et al. Among authors: strater r. Arch Dis Child Fetal Neonatal Ed. 1998 Mar;78(2):F121-4. doi: 10.1136/fn.78.2.f121. Arch Dis Child Fetal Neonatal Ed. 1998. PMID: 9577282 Free PMC article.

4

Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.

Nowak-Göttl U, Sträter R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A. Nowak-Göttl U, et al. Among authors: strater r. Blood. 1999 Dec 1;94(11):3678-82. Blood. 1999. PMID: 10572079 Free article.

5

Genetic risk factors of thrombophilia in ischaemic childhood stroke of cardiac origin. A prospective ESPED survey.

Sträter R, Vielhaber H, Kassenböhmer R, von Kries R, Göbel U, Nowak-Göttl U. Sträter R, et al. Eur J Pediatr. 1999 Dec;158 Suppl 3:S122-5. doi: 10.1007/pl00014336. Eur J Pediatr. 1999. PMID: 10650850

6

Symptomatic ischemic stroke in full-term neonates : role of acquired and genetic prothrombotic risk factors.

Günther G, Junker R, Sträter R, Schobess R, Kurnik K, Heller C, Kosch A, Nowak-Göttl U; Childhood Stroke Study Group. Günther G, et al. Among authors: strater r. Stroke. 2000 Oct;31(10):2437-41. doi: 10.1161/01.str.31.10.2437. Stroke. 2000. PMID: 11022077 Clinical Trial.

7

The plasminogen activator inhibitor (PAI)-1 promoter 4G/4G genotype is not associated with ischemic stroke in a population of German children. Childhood Stroke Study Group.

Nowak-Göttl U, Sträter R, Kosch A, von Eckardstein A, Schobess R, Luigs P, Nabel P, Vielhaber H, Kurnik K, Junker R. Nowak-Göttl U, et al. Among authors: strater r. Eur J Haematol. 2001 Jan;66(1):57-62. doi: 10.1034/j.1600-0609.2001.00338.x. Eur J Haematol. 2001. PMID: 11168509

8

[Cockayne syndrome with marked cerebral symptoms].

Menges-Wenzel EM, Debus O, Sträter R, Schuierer G, Kurlemann G. Menges-Wenzel EM, et al. Among authors: strater r. Klin Padiatr. 2001 May-Jun;213(3):134-8. doi: 10.1055/s-2001-15864. Klin Padiatr. 2001. PMID: 11417366 German.

9

Aspirin versus low-dose low-molecular-weight heparin: antithrombotic therapy in pediatric ischemic stroke patients: a prospective follow-up study.

Sträter R, Kurnik K, Heller C, Schobess R, Luigs P, Nowak-Göttl U. Sträter R, et al. Stroke. 2001 Nov;32(11):2554-8. doi: 10.1161/hs1101.097379. Stroke. 2001. PMID: 11692016 Clinical Trial.

10

Prospective assessment of risk factors for recurrent stroke during childhood--a 5-year follow-up study.

Sträter R, Becker S, von Eckardstein A, Heinecke A, Gutsche S, Junker R, Kurnik K, Schobess R, Nowak-Göttl U. Sträter R, et al. Lancet. 2002 Nov 16;360(9345):1540-5. doi: 10.1016/S0140-6736(02)11520-0. Lancet. 2002. PMID: 12443591

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters